Defining the process parameters affecting the fabrication of rosuvastatin calcium nanoparticles by planetary ball mill

References

• Junghanns JAH, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed. 2008;3:295–309. PMCID: PMC2626933.
   PubMed Web of Science ®Google Scholar
• Kumar CSSR. Nanotechnology tools in pharmaceutical R&D. Materialstoday. 2009;12:24–30. Electron microscopy special issue. ISSN:1369 7021 © Elsevier Ltd. doi:10.1016/S1369-7021(10)70142-5
   Web of Science ®Google Scholar
• Alshora D, Ibrahim MA, Alanazi FK. Nanotechnology from particle size reduction to enhancing aqueous solubility In: Grumezescu AM, editor. Surface Chemistry of Nanobiomaterials. Application of Nanobiomaterials. Vol. 3 Cambridge, USA: Elsevier; 2016:163–191.
   Google Scholar
• Fritsch: Planetary ball mill. Retrieved from: http://www.fritsch-international.com/sample-preparation/milling/planetary-mills/details/product/pulverisette-7-premium-line/. Accessed 11, 2017.
   Google Scholar
• Shahbaziniaza M, Foroutana SM, Bolourchiana N. Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formation. Iran J Pharm Res. 2013;12(4):587–598.24523739
   PubMed Web of Science ®Google Scholar
• Patnaik S, Kurdekar AD, Chunduri LAA, Prathibha C, Sai Vamsi Krishna V, Venkataramaniah K. Naproxen-soluplus® nano formulations for enhanced oral bioavailability. Int J Pharm. 2017;7:99–112.
   Google Scholar
• Kamble PR, Shaikh KS, Chaudhari PD. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin. Adv Pharm Bull. 2014;4:197–204. doi:10.5681/apb.2014.02924511485
   PubMedGoogle Scholar
• Ramu A, Vidyadhara S, Devanna N, Anusha C, Keerthi J. Formulation and evaluation of rosuvastatin fast dissolving tablets. Asian J Chem. 2013;25:5340–5346. doi:10.14233/ajchem
   Google Scholar
• Akbari BV, Valaki BP, Maradiya VH, Akbari AK, Vidyasagar G. Enhancement of solubilityand dissolution rate of rosuvastatin calcium by complexation with β-cyclodextrin. Int J Pharm Biol Arch. 2011;2:511–520.
   Google Scholar
• Amrutkar C, Salunkhe K, Chaudhari S. Study on self-nano emulsifying drug delivery system of poorly water- soluble drug rosuvastatin calcium. World J Pharm Res. 2014;3:2137–2151.
   Google Scholar
• Gabr MM, Mortada SM, Sallam MA. Carboxylate cross-linked cyclodextrin: a nanoporous scaffold for enhancement of rosuvastatin oral bioavailability. Eur J Pharm Sci. 2018;111:1–12. doi:10.1016/j.ejps.2017.09.02628931488
   PubMed Web of Science ®Google Scholar
• Gabr MM, Mortada SM, Sallam MA. Hexagonal liquid crystalline nanodispersions proven puperiority for enhanced oral delivery of rosuvastatin: in vitro characterization and in vivo pharmacokinetic study. J Pharm Sci. 2017;106:3103–3112. doi:10.1016/j.xphs.2017.04.06028479357
   PubMed Web of Science ®Google Scholar
• Stengera F, Mendeb S, Schwedesc J, Peukertd W. Media milling in stirred media mills. Chem Eng Sci. 2005;60:4557–4565. doi:10.1016/j.ces.2005.02.057
   Web of Science ®Google Scholar
• Alshora DH, Ibrahim MA, Elzayat E, Almeanazel OT, Alanazi F. Rosuvastatin calcium nanoparticles: improving bioavailability by formulation and stabilization codesign. PLoS One. 2018;13(7):1–17. doi:10.1371/journal.pone.0200218
   Web of Science ®Google Scholar
• Ngwuluka NC, Lawal K, Olorunfemi PO, Ochekpe NA. Post-market in vitro bioequivalence study of six brands of ciprofloxacin tablets/caplets in Jos, Nigeria. Sci Res Essay. 2009;4(4):298–305.
   Google Scholar
• Harmonisation ICH. Guidance for Industry Q1A (R2) Stability Testing of New Drug Substances and Products. Silver Spring: US Department of Health and Human Services, Food and Drug Administration; 2003.
   Google Scholar
• Canakci A, Erdemir F, Varol T, Patir A. Determining the effect of process parameters on particle size in mechanical milling using the Taguchi method: measurement and analysis. Measurement. 2013;46:3532–3540. doi:10.1016/j.measurement.2013.06.035
   Web of Science ®Google Scholar
• Liu P, Rong X, Laru J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411:215–222. doi:10.1016/j.ijpharm.2011.03.05021458552
   PubMed Web of Science ®Google Scholar
• Knieke C, Sommer M, Peukert W. Identifying the apparent and true grinding limit. Powder Technol. 2009;195:25–30. doi:10.1016/j.powtec.2009.05.007
   Web of Science ®Google Scholar
• Bartos C, Szabó-Révész P, Bartos C, Katona G, Jójárt-Laczkovich O, Ambrus R. The effect of an optimized wet milling technology on the crystallinity, morphology and dissolution properties of micro- and nanonized meloxicam. Molecules. 2016;21(507):1–11. doi:10.3390/molecules21040507
   Google Scholar
• Ghosh I, Schenck D, Bose S, Ruegger C. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of vitamin E TPGS and nanocrystal particle size on oral absorption. Eur J Pharm Sci. 2012;47:718–772. doi:10.1016/j.ejps.2012.08.01122940548
   PubMed Web of Science ®Google Scholar
• Nijlen TV, Brennan K, Mooter GV, Blaton N, Kinget R, Augustijns P. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. Int J Pharm. 2003;254:173–181. doi:10.1016/S0378-5173(03)00009-712623193
   PubMed Web of Science ®Google Scholar
• Patel DD. Kinetics and mechanisms of crystal growth inhibition of indomethacin by model precipitation inhibitors. [doctoral thesis]. Lexington: University of Kentucky; 2015.
   Google Scholar
• Haq N, Shakeel F, Alanazi FK, Alshora DH, Ibrahim MA. Development and validation of a ‘green’ RP-HPLC method for the analysis of rosuvastatin: a step towards making liquid chromatography environmentally benign. Green Proc Synth. 2018;7:160–169. doi:10.1515/gps-2017-0023
   Web of Science ®Google Scholar